Free CME on Managing Risk in Patients with RA thru 4/29/11

Managing Risk in Patients with RA: Focus on Demyelinating Conditions

Earn 1.0 credit through the Cleveland Clinic.

On completion of this activity, participants should be able to:

1. Assess the risk for developing a demyelinating condition when a patient is receiving treatment for inflammatory arthritis.
2. Describe the presentation of demyelinating disease in a patient being treated for RA.
3. Discuss specific demyelinating disorders reported in patients receiving an immunosuppressant for inflammatory arthritis.

This activity is supported by an educational donation provided by Amgen.
This activity is supported by an educational grant from Bristol-Myers Squibb Company.
This activity is supported by an educational grant from Centocor Ortho Biotech Services.
This activity is supported by an independent educational grant from Roche Laboratories, Inc.